ROZZINI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 8.028
AS - Asia 3.779
EU - Europa 3.573
SA - Sud America 707
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 121
OC - Oceania 6
Totale 16.395
Nazione #
US - Stati Uniti d'America 7.874
CN - Cina 1.380
SG - Singapore 1.159
UA - Ucraina 847
BR - Brasile 578
IT - Italia 546
PL - Polonia 520
DE - Germania 504
HK - Hong Kong 413
FI - Finlandia 313
VN - Vietnam 241
FR - Francia 216
GB - Regno Unito 203
BD - Bangladesh 171
RU - Federazione Russa 137
IE - Irlanda 122
TR - Turchia 121
IN - India 103
CA - Canada 72
NG - Nigeria 60
AR - Argentina 50
MX - Messico 40
SE - Svezia 28
IQ - Iraq 27
JP - Giappone 24
ZA - Sudafrica 24
NL - Olanda 23
ID - Indonesia 21
BE - Belgio 20
PK - Pakistan 20
AT - Austria 19
EC - Ecuador 18
IR - Iran 17
VE - Venezuela 15
MA - Marocco 14
SA - Arabia Saudita 12
CO - Colombia 11
ES - Italia 11
PY - Paraguay 11
UZ - Uzbekistan 11
CL - Cile 10
CH - Svizzera 8
JM - Giamaica 8
KR - Corea 8
CZ - Repubblica Ceca 7
EU - Europa 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
JO - Giordania 6
PE - Perù 6
TW - Taiwan 6
HN - Honduras 5
LV - Lettonia 5
AL - Albania 4
EG - Egitto 4
KE - Kenya 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
GT - Guatemala 3
KW - Kuwait 3
MU - Mauritius 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
PS - Palestinian Territory 3
SV - El Salvador 3
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
EE - Estonia 2
GE - Georgia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
BJ - Benin 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
Totale 16.206
Città #
Fairfield 974
Woodbridge 792
Ashburn 685
Singapore 600
Jacksonville 557
Warsaw 519
Houston 508
Hong Kong 412
Wilmington 376
Seattle 367
Cambridge 363
Ann Arbor 307
San Jose 267
Beijing 262
Princeton 221
Nanjing 219
The Dalles 216
Chandler 208
New York 190
Helsinki 188
Los Angeles 125
Dublin 122
Brescia 121
Columbus 104
Istanbul 104
Lauterbourg 102
Munich 95
Milan 87
Ho Chi Minh City 81
Dallas 75
Nanchang 72
Buffalo 61
Abuja 58
Hebei 55
Des Moines 50
Moscow 48
Shanghai 48
São Paulo 48
San Diego 46
Changsha 45
Dearborn 44
Hanoi 43
Jinan 41
Tianjin 41
San Francisco 39
Shenyang 38
Redondo Beach 37
Council Bluffs 30
Nuremberg 30
Jiaxing 27
Santa Clara 27
Hangzhou 26
Chicago 25
Orem 25
Turku 25
Kunming 23
Montreal 23
Dong Ket 22
Toronto 22
Verona 22
Brussels 19
London 19
Rome 19
Denver 18
Phoenix 18
Zhengzhou 18
Boardman 17
Guangzhou 16
Rio de Janeiro 16
San Mateo 16
Brooklyn 15
Mumbai 15
Ningbo 15
Augusta 14
Lanzhou 14
Poplar 14
Ardabil 13
Frankfurt am Main 13
Johannesburg 13
Stockholm 13
Tokyo 13
Belo Horizonte 12
Manchester 12
Mexico City 12
Newton Abbot 12
Amsterdam 11
Bologna 11
Charlotte 11
Chennai 11
Jakarta 11
Tashkent 11
Atlanta 10
Boston 10
Da Nang 10
Haikou 10
Leawood 10
Washington 10
Baghdad 9
Osasco 9
Salò 9
Totale 10.917
Nome #
Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. 364
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 357
Behavioral disorders in Alzheimer disease: a transcultural perspective 291
Gene expression profile in fibroblasts of Huntington's disease patients and controls 283
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 269
COVID-19 impact on consecutive neurological patients admitted to the emergency department 265
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. 250
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 240
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 223
Gene expression profile in fibroblasts of Huntington's disease patients and controls. 218
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 210
A case report: doctor, my daughter has Alzheimer's disease. 202
Depressive disorders in dementia. 200
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 200
The Italian version of the pain assessment in advanced dementia (PAINAD) scale 198
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 194
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 191
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 184
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 180
Cognitive dysfunction and age-related macular degeneration. 179
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 178
Severe worsening of parkinsonism in Lewy body dementia due to donepezil. 175
Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. 175
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 170
Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease. 169
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. 169
Diagnosis disclosure and advance care planning in Alzheimer disease: opinions of a sample of Italian citizens. 167
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 167
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease. 165
Gene expression profile in fibroblasts of Huntington's disease patients and controls 164
Alzheimer disease and frontotemporal dementia. 161
Anxiety symptoms in mild cognitive impairment. 159
The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia due to Alzheimer's Disease in Routine Clinical Practice 158
Prestroke dementia: characteristics and clinical features in consecutive series of patients. 155
Behavioral syndromes in Alzheimer's disease: description and correlates. 153
Predictors of progression from mild cognitive impairment to Alzheimer disease. 151
Pre-stroke and post-stroke dementia: Preliminary data from an Italian study 150
Free copper in serum: An analytical challenge and its possible applications 150
Procedural memory stimulation in Alzheimer's disease: impact of a training programme. 149
Does reversible MCI exist? 149
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment 148
Does age at observation time affect the clinical presentation of mild cognitive impairment? 148
Do vascular risk factors play a role in the progression of mild cognitive impairment? 146
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 144
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 142
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study. 142
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study 139
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 137
Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. 136
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 135
Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. 133
Object and action naming in Alzheimer's disease and frontotemporal dementia 132
Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. 132
Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. 131
Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. 131
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease 131
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study 130
Alteration of APP processing in platelets and CSF of AD patients European 128
The migraine-PFO connection is independent of sex. 128
The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. 127
Transient global amnesia and venous flow patterns. 126
Surface dyslexia in an Italian patient with semantic dementia 126
Microvascular damage and platelet abnormalities in early Alzheimer's disease. 125
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease. 125
The impact of cognitive deficit on self-reported car crashes in ultra-octogenarian population: data of an Italian population-based study. 125
Spatial navigation in elderly healthy subjects, amnestic and non amnestic MCI patients 124
Changes in characteristics of Alzheimer patients at first visit to centers for dementia: a 10-year follow-up study. 122
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study. 122
Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. 121
Assessment of platelet Amyloid Precursor Protein forms ratio in patients with mild cognitive impairment: A tool for the identification of preclinical Alzheimer Disease 121
Acetylcholinestfrase inhibitors are effective in "real world" patients with mild to moderate Alzheimer disease: Evidence from a large population treated with rivastigmine or donepezil 119
Transient global amnesia and disturbance of venous flow patterns 119
App isoforms ratio in platelets: A peripheral marker for the diagnosis and treatment of Alzheimer's disease? 118
Transient global amnesia: a clinical and sonographic study 117
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. 116
Volume reduction in cerebral blood flow in patients with Alzheimer’s disease. A sonographic study 116
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 114
Predictors of institutionalization in demented patients discharged from a rehabilitation unit 114
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 113
Efficacy of SSRI on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors 113
Knowledge and attitudes about Alzheimer's disease in the lay public: influence of caregiving experience and other socio-demographic factors in an Italian sample. 112
Peripheral oedema related to quetiapine therapy : a case report. 111
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. 110
Aspetti etici delle demenze 109
Clinical correlates of executive dysfunctions in mild cognitive impairment 109
Parkinsonian signs in subjects with mild cognitive impairment 108
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. 104
Apolipoprotein E allele and platelets amyloid precursor protein in Alzheimer's disease: Biological effect of acetylcholinesterase inhibitors treatment 102
Depression is unrelated to conversion to dementia in patients with mild cognitive impairment. 100
Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study 99
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 99
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 97
Short-term memory binding in mild cognitive impairment: a preclinical marker of Alzheimer's disease? 93
Predictors of recurence in paradoxical cerebral embolism 92
“Real-world” eligibility for aducanumab depends on clinical setting and patients' journey 92
Vascular risk factors for VaD and AD in a population-based prospective cohort. The PAQUID study 91
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 91
Retrograde jugular venous flow is a predisposing factor in transient global amnesia. 89
P-Tau as prognostic marker in long term follow up for patients with shunted iNPH 89
L’Istituto di Riabilitazione Geriatrica (IDRG): un modello clinico-assistenziale per le demenze? 85
Totale 15.030
Categoria #
all - tutte 73.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022820 0 198 9 39 7 36 53 56 50 101 55 216
2022/2023691 129 21 12 35 65 207 6 61 91 4 25 35
2023/2024740 48 25 73 43 21 123 29 26 213 13 9 117
2024/20251.963 10 22 22 268 239 169 222 53 213 117 402 226
2025/20264.275 355 551 315 638 354 308 634 198 236 343 191 152
2026/2027324 264 60 0 0 0 0 0 0 0 0 0 0
Totale 16.395